This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • NGR019: Randomized double-blind phase II study of ...
Clinical trial

NGR019: Randomized double-blind phase II study of NGR-hTNF versus placebo as maintenance treatment in advanced malignant pleural mesothelioma (MPM)

Read time: 1 mins
Last updated:3rd Feb 2011
To compare progression-free survival (PFS) in patients randomized to NGR-hTNF versus patients randomized to placebo
Category Value
Study start date 2011-02-03

View full details